Could a common HIV drug hold the key to taming multiple sclerosis?
NCT ID NCT05957913
Summary
This study is testing whether Truvada, an antiviral medication, can reduce levels of Epstein-Barr virus (EBV) in people with multiple sclerosis (MS). Researchers believe EBV might trigger MS, so lowering the virus could help control the disease. The trial will enroll 50 adults with MS who have EBV to see if the drug is safe and reduces virus levels in saliva and blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.